Skip to content

Public FDA record

Z-2602-2021: DxA 5000 (DxA Automation System, DxA 5000 fit), "For in Vitro Diagnostic Use", Reference Numbers: B87352

Recall record Z-2602-2021 for Beckman Coulter Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2602-2021
Company in FDA record
Beckman Coulter Inc.
FDA record creation date
Sep 30, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is a potential that sample carriers (w or w/o samples) within automated sampling system may transport samples to the outer lane which does not contain a physical barrier to restrain samples. Samples are dropped when they reach the end of the outer lane which could result in Delay in providing patient with appropriate medical treatment. New sample needs to be drawn. Substantial discharge of biohazards material - Infection with a human transmissible blood-borne or animal pathogen which could result in Infection with a human transmissible blood-borne pathogen (e.g. infectious HBV, HCV, HIV).

Source facts

Action
On August 9 & 11, 2021 Beckman Coulter issued a "Urgent Medical Device Recall" Notification via: E-Mail and paper mail. In addition, to informing consignee about the recall device, the firm ask consignees to take the following actions: 1. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. 2. If the DxA System is observed to be routing sample carriers to the outer lane of the Single Drive Transport Segment (B57634), please report your observation to Beckman Coulter. 3. When conducting maintenance or trouble-shooting sample carriers on the DxA transport system, follow the instructions as given in the DxA Instructions for Use, especially with respect to correctly remove and re-introduce sample tubes. Please note that there is the option to set up the delayed sample tracking function in Remisol Advance Software, that alerts the user to potentially impacted samples. Please refer to the chapter "dashboard & reporting - tracking of delayed samples in Remisol" in the Instruction for Use of Remisol Advance. 4. Beckman Coulter will be providing a physical stopper solution to be installed on the single drive segment by Beckman coulter Service or authorize Field Service Engineers. 5. Please complete and return the enclosed Response Form within 10 days so we are assured you have received this important communication. 6. If you have any questions regarding this notice, please contact our customer Support Center via our website: http://www.beckmancoulter.com. 7. In case you experience adverse reactions or quality problems with the use of this product you may report them to the FDA s MedWatch Adverse Event Reporting program (https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program ) in addition to reporting to Beckman Coulter via our website: http://www.beckmancoulter.com or your local Beckman Coulter representative by phone.
Initiated
2021-07-21
Root cause
Under Investigation by firm
Terminated
2024-10-10
Distribution
US Nationwide distribution in the states of AL, CA, IL, In, KY, MN, MI, OH, PA, TX, WV.
Recall number
Z-2602-2021
Recall status
Terminated
CDRH record ID
188892
FDA record created
2021-09-30
Recall event number
88519

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗